Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles

WuXi Biologics Begins Construction of $1.4 Billion Singapore CRDMO Facility
Merck KGaA to Build $326 Million Bioprocessing Production Center in Korea
Novo Nordisk Invests $556 Million In Tianjin Manufacturing Plant for Weight Loss Drug
Antengene Starts Dose Expansion in Trial of Claudin 18.2 ADC
WuXi AppTec Reports 2023 Results; US Biopharmas Are 65% of Its Business
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital